“The FDA has approved a new kind of insulin injection for type 2 diabetes that only needs to be used once a week, rather than the standard daily dose,” reports The Doomslayer.
“Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved Awiqli® (insulin icodec-abae) injection 700 units/mL, the first and only once-weekly, long-acting basal insulin, indicated as an adjunct to diet and exercise to improve glycemic control (blood sugar) in adults living with type 2 diabetes.”
In other news, sugar prices have fallen as anti-obesity drugs resulted in people eating less sweets.
America is one of the ten fattest countries in the world, but it has stopped getting fatter, due to weight loss drugs. ““Gallup polling finds that self-reported obesity in the US has been falling since 2022, an encouraging finding that is broadly consistent with CDC data showing a small recent dip in measured obesity rates.”
The weight-loss drug Ozempic may be helpful not just in fighting obesity and diabetes, but also in slowing the effects of Alzheimer’s disease.
A single pill can now cure the deadly disease of sleeping sickness.
